Company Overview - Perimeter Acquisition Corp. I is a special purpose acquisition company targeting companies in the defense and national security sectors, leveraging its management's extensive investment and operational experience [5] - The company also aims to explore opportunities at the intersection of defense, technology, and national security, believing its management team can drive value creation post-business combination [5] Initial Public Offering (IPO) Details - The company announced the pricing of its upsized initial public offering of 21,000,000 units at $10.00 per unit, with units expected to trade on Nasdaq under the ticker symbol "PMTRU" starting May 13, 2025 [1] - The offering is anticipated to close on May 14, 2025, subject to customary closing conditions, with Citigroup Global Markets Inc. serving as the sole book-running manager [2] - An additional 3,150,000 units may be purchased by the underwriter to cover over-allotments [2] Regulatory and Compliance Information - A registration statement on Form S-1 related to these securities has been filed with the SEC and was declared effective on May 12, 2025, with the offering being made only by means of a prospectus [3]

Core Viewpoint - Apimeds Pharmaceuticals US, Inc. has announced the pricing of its initial public offering (IPO) of 3,375,000 shares at $4.00 per share, aiming to raise approximately $13.5 million in gross proceeds [1][2]. Group 1: IPO Details - The IPO is expected to close on May 12, 2025, and shares will begin trading on the NYSE American under the symbol "APUS" on May 9, 2025 [2]. - The underwriters have a 45-day option to purchase an additional 506,250 shares at the public offering price, and they have been issued warrants for up to 168,750 shares [2]. Group 2: Use of Proceeds - The net proceeds from the IPO will be utilized to fund a Phase III clinical trial for knee osteoarthritis, initiate a corporate sponsorship study in multiple sclerosis, manufacture the product candidate, and cover general working capital needs [3]. Group 3: Company Overview - Apimeds is a clinical stage biopharmaceutical company developing Apitox, a bee venom-based toxin administered intradermally, which is being targeted as a treatment for osteoarthritis in patients who do not respond to conventional therapies [6].

NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Dune Acquisition Corporation II (the “Company”) announced today the closing of its initial public offering of 14,375,000 units, including the exercise in full of the underwriters’ over-allotment option. The offering was priced at $10.00 per unit, resulting in gross proceeds of $143,750,000. The units are listed on the Nasdaq Global Market (the “Nasdaq”) and commenced trading under the ticker symbol “IPODU” on May 7, 2025. Each unit consists of one Class A ordinary ...

NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Dune Acquisition Corporation II (the “Company”) announced today the pricing of its initial public offering of 12,500,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq Global Market (the “Nasdaq”) and trade under the ticker symbol “IPODU” beginning on May 7, 2025. Each unit consists of one Class A ordinary share and three-quarters of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a ...

Group 1 - The Company, Republic Digital Acquisition Company, closed its initial public offering (IPO) of 30,000,000 units, including 3,600,000 units from the underwriters' over-allotment option, resulting in gross proceeds of $300,000,000 priced at $10.00 per unit [1][3] - The units began trading on May 1, 2025, on Nasdaq under the ticker symbol "RDAGU," with each unit consisting of one Class A ordinary share and one-half of a redeemable warrant, which can be exercised at $11.50 per share [2][4] - The Company is a blank check company formed to pursue mergers or acquisitions, focusing on opportunities in fintech, software, and cryptocurrency industries [4][5] Group 2 - The management team includes Joseph Naggar as CEO, Ian Goodman as CFO, Jonathan Knipper as COO, and Darren Sandler as General Counsel, with additional board members [5] - Cantor Fitzgerald & Co. acted as the sole book-running manager for the offering [5] - A registration statement for the securities was declared effective by the SEC on April 30, 2025 [6]

Company Overview - Republic Digital Acquisition Company is a blank check company formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses [2] - The company plans to focus on acquisition opportunities in the fintech, software, and cryptocurrency industries [2] Initial Public Offering (IPO) Details - The company announced an upsized initial public offering of 26,400,000 units at a price of $10.00 per unit, with trading expected to begin on May 1, 2025, under the ticker symbol "RDAGU" [1] - Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with whole warrants allowing the purchase of one Class A ordinary share at a price of $11.50 per share [1] - An amount equal to $10.00 per unit will be deposited into a trust account upon the closing of the offering, which is expected to close on May 2, 2025 [1] - The underwriters have been granted a 45-day option to purchase up to an additional 3,960,000 units at the initial public offering price to cover over-allotments [1] Management Team - The management team is led by Joseph Naggar as Chief Executive Officer, Chief Investment Officer, and Director, along with Ian Goodman as Chief Financial Officer [3] - The Board of Directors includes Andrew Durgee, Barry Finkelstein, Laya Khadjavi, and Robert Matza [3] - Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering [3]

HONG KONG, April 30, 2025 (GLOBE NEWSWIRE) -- Copley Acquisition Corp (NYSE: COPLU) (the “Company”) announced today the pricing of its initial public offering of 15,000,000 units at $10.00 per unit. The units are expected to be listed on the New York Stock Exchange (“NYSE”) and trade under the ticker symbol “COPLU” beginning May 1, 2025. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary sh ...

Group 1 - Digital Asset Acquisition Corp. closed its initial public offering (IPO) of 17,250,000 units at a public offering price of $10.00 per unit, including 2,250,000 units from the underwriters' over-allotment option [1][2] - Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share [1] - The company also closed a private placement of 5,450,000 warrants at $1.00 per warrant, generating gross proceeds of $5,450,000, with a total of $172,500,000 placed in trust from the IPO and private placement [3] Group 2 - Digital Asset Acquisition Corp. is a blank check company aimed at effecting a merger or similar business combination, specifically targeting opportunities in the digital asset and cryptocurrency sectors [4] - Cohen & Company Capital Markets acted as the lead book-running manager for the offering, while Clear Street LLC served as the joint book-runner [5]

Group 1 - Real Asset Acquisition Corp. closed its initial public offering (IPO) of 17,250,000 units at a public offering price of $10.00 per unit, including 2,250,000 units from the underwriters' over-allotment option [1][2] - Each unit consists of one Class A ordinary share and one-half of a redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 [1] - The IPO proceeds included $172,500,000 placed in trust, corresponding to $10.00 per unit sold in the public offering [3] Group 2 - Concurrently with the IPO, the company closed a private placement of 5,450,000 warrants at $1.00 per warrant, generating gross proceeds of $5,450,000 [3] - The company intends to target opportunities in quantum computing, metals/mining, rare earth, and infrastructure sectors for its initial business combination [4] Group 3 - The units began trading on Nasdaq under the ticker symbol "RAAQU" on April 29, 2025, with Class A ordinary shares and warrants expected to be listed under "RAAQ" and "RAAQW," respectively [2] - Cohen & Company Capital Markets acted as the lead book-running manager, while Clear Street LLC served as the joint book-runner for the offering [5]

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. NEW YORK, April 29, 2025 (GLOBE NEWSWIRE) -- Inflection Point Acquisition Corp. III (the "Company"), a special purpose acquisition company formed for the purpose of effecting a ...